As of 1:30 PM on the 2nd, Jin Matrix is trading at 14,650 KRW, up 1.03% from the previous day. This represents a 22.08% increase compared to June 23. Jin Matrix is known as a company specializing in the development of diagnostic agents through biotechnology research.
Over the past 5 days, individual investors have net purchased 21,832 shares, while foreigners and institutions have net purchased 21,604 shares and net sold 50,081 shares, respectively.
On June 24, Jin Matrix became a market issue with the news of "28% surge due to October supply of COVID-19 vaccine."
※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
